SUBSCRIBE NOW
$5 for 3 months. Save 83%.
SUBSCRIBE NOW
$5 for 3 months. Save 83%.

Bayer to pay up to $10.9 billion to settle Roundup case

Associated Press

Berlin – German pharmaceutical company Bayer says it’s paying up to $10.9 billion to settle a lawsuit over subsidiary Monsanto’s weedkiller Roundup, which has faced numerous lawsuits over claims it causes cancer.

In a statement Wednesday, Bayer said it was also paying up $1.22 billion to settle two further cases, one involving PCB in water.

The Leverkusen-based company said the Roundup settlement would “bring closure to approximately 75%” of the current 125,000 filed and unfiled claims.

Germany plans to ban the use of glyphosate, the active ingredient in weed killer Roundup, over concerns it is leading to a decline of bees and other insects. The Cabinet agreed Wednesday to start phasing out glyphosate next year and ban all use in Germany by the end of 2023.

It said the agreement is subject to approval by Judge Vince Chhabria of the U.S. District Court for the Northern District of California.

Bayer said it would also pay up to $400 million to settle cases involving the weedkiller dicamba having drifted onto plants that weren’t bred to resist it, killing them.

A further payment of up to $820 million will be made to settle “most” claims for exposure to PCB, a highly carcinogenic substance, that Monsanto produced until 1977 and which has been found in U.S. waters

Bayer said it would start making payments this year and these would be financed from existing liquidity, future income, proceeds from the sale of its animal health business and the issuance of additional bonds.